Global Non-invasive DNA Prenatal Testing Market Growth (Status and Outlook) 2026-2032
The global Non-invasive DNA Prenatal Testing market size is predicted to grow from US$ 722 million in 2025 to US$ 1541 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual?s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
LPI (LP Information)' newest research report, the ?Non-invasive DNA Prenatal Testing Industry Forecast? looks at past sales and reviews total world Non-invasive DNA Prenatal Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive DNA Prenatal Testing sales for 2026 through 2032. With Non-invasive DNA Prenatal Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive DNA Prenatal Testing industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive DNA Prenatal Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive DNA Prenatal Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-invasive DNA Prenatal Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive DNA Prenatal Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive DNA Prenatal Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive DNA Prenatal Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual?s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
LPI (LP Information)' newest research report, the ?Non-invasive DNA Prenatal Testing Industry Forecast? looks at past sales and reviews total world Non-invasive DNA Prenatal Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive DNA Prenatal Testing sales for 2026 through 2032. With Non-invasive DNA Prenatal Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive DNA Prenatal Testing industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive DNA Prenatal Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive DNA Prenatal Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-invasive DNA Prenatal Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive DNA Prenatal Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive DNA Prenatal Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive DNA Prenatal Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive DNA Prenatal Testing Market Size (2021-2032)
2.1.2 Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-invasive DNA Prenatal Testing by Country/Region (2021, 2025 & 2032)
2.2 Non-invasive DNA Prenatal Testing Segment by Type
2.2.1 Core Condition Screening
2.2.2 Expanded Condition Screening
2.2.3 Non-invasive DNA Prenatal Testing Market Size by Type
2.2.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
2.3 Non-invasive DNA Prenatal Testing Segment by Sequencing Method
2.3.1 Whole Genome Sequencing
2.3.2 Targeted Sequencing
2.3.3 Others
2.3.4 Non-invasive DNA Prenatal Testing Market Size by Sequencing Method
2.3.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2026)
2.4 Non-invasive DNA Prenatal Testing Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Non-invasive DNA Prenatal Testing Market Size by Service Model
2.4.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2026)
2.5 Non-invasive DNA Prenatal Testing Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Non-invasive DNA Prenatal Testing Market Size by Application
2.5.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE DNA PRENATAL TESTING MARKET SIZE BY PLAYER
3.1 Non-invasive DNA Prenatal Testing Market Size Market Share by Player
3.1.1 Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
3.2 Global Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DNA PRENATAL TESTING BY REGION
4.1 Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
4.2 Global Non-invasive DNA Prenatal Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.4 APAC Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.5 Europe Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
5.2 Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3 Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
6.2 APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
6.3 APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
7.2 Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive DNA Prenatal Testing by Region (2021-2026)
8.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DNA PRENATAL TESTING MARKET FORECAST
10.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.2 Americas Non-invasive DNA Prenatal Testing Forecast
10.1.3 APAC Non-invasive DNA Prenatal Testing Forecast
10.1.4 Europe Non-invasive DNA Prenatal Testing Forecast
10.1.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast
10.2 Americas Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.2.1 United States Market Non-invasive DNA Prenatal Testing Forecast
10.2.2 Canada Market Non-invasive DNA Prenatal Testing Forecast
10.2.3 Mexico Market Non-invasive DNA Prenatal Testing Forecast
10.2.4 Brazil Market Non-invasive DNA Prenatal Testing Forecast
10.3 APAC Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.3.1 China Non-invasive DNA Prenatal Testing Market Forecast
10.3.2 Japan Market Non-invasive DNA Prenatal Testing Forecast
10.3.3 Korea Market Non-invasive DNA Prenatal Testing Forecast
10.3.4 Southeast Asia Market Non-invasive DNA Prenatal Testing Forecast
10.3.5 India Market Non-invasive DNA Prenatal Testing Forecast
10.3.6 Australia Market Non-invasive DNA Prenatal Testing Forecast
10.4 Europe Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Non-invasive DNA Prenatal Testing Forecast
10.4.2 France Market Non-invasive DNA Prenatal Testing Forecast
10.4.3 UK Market Non-invasive DNA Prenatal Testing Forecast
10.4.4 Italy Market Non-invasive DNA Prenatal Testing Forecast
10.4.5 Russia Market Non-invasive DNA Prenatal Testing Forecast
10.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-invasive DNA Prenatal Testing Forecast
10.5.2 South Africa Market Non-invasive DNA Prenatal Testing Forecast
10.5.3 Israel Market Non-invasive DNA Prenatal Testing Forecast
10.5.4 Turkey Market Non-invasive DNA Prenatal Testing Forecast
10.6 Global Non-invasive DNA Prenatal Testing Forecast by Type (2027-2032)
10.7 Global Non-invasive DNA Prenatal Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-invasive DNA Prenatal Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Natera
11.1.1 Natera Company Information
11.1.2 Natera Non-invasive DNA Prenatal Testing Product Offered
11.1.3 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Natera Main Business Overview
11.1.5 Natera Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Non-invasive DNA Prenatal Testing Product Offered
11.2.3 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Non-invasive DNA Prenatal Testing Product Offered
11.3.3 Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Non-invasive DNA Prenatal Testing Product Offered
11.4.3 MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product Offered
11.5.3 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 SYNLAB
11.6.1 SYNLAB Company Information
11.6.2 SYNLAB Non-invasive DNA Prenatal Testing Product Offered
11.6.3 SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SYNLAB Main Business Overview
11.6.5 SYNLAB Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Non-invasive DNA Prenatal Testing Product Offered
11.7.3 Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 GGA
11.8.1 GGA Company Information
11.8.2 GGA Non-invasive DNA Prenatal Testing Product Offered
11.8.3 GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GGA Main Business Overview
11.8.5 GGA Latest Developments
11.9 Fulgent Genetics
11.9.1 Fulgent Genetics Company Information
11.9.2 Fulgent Genetics Non-invasive DNA Prenatal Testing Product Offered
11.9.3 Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fulgent Genetics Main Business Overview
11.9.5 Fulgent Genetics Latest Developments
11.10 BillionToOne
11.10.1 BillionToOne Company Information
11.10.2 BillionToOne Non-invasive DNA Prenatal Testing Product Offered
11.10.3 BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BillionToOne Main Business Overview
11.10.5 BillionToOne Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Non-invasive DNA Prenatal Testing Product Offered
11.11.3 BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Berry Genomics
11.12.1 Berry Genomics Company Information
11.12.2 Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
11.12.3 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Genomics Main Business Overview
11.12.5 Berry Genomics Latest Developments
11.13 Annaroad
11.13.1 Annaroad Company Information
11.13.2 Annaroad Non-invasive DNA Prenatal Testing Product Offered
11.13.3 Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Annaroad Main Business Overview
11.13.5 Annaroad Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Non-invasive DNA Prenatal Testing Product Offered
11.14.3 Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product Offered
11.15.3 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive DNA Prenatal Testing Market Size (2021-2032)
2.1.2 Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-invasive DNA Prenatal Testing by Country/Region (2021, 2025 & 2032)
2.2 Non-invasive DNA Prenatal Testing Segment by Type
2.2.1 Core Condition Screening
2.2.2 Expanded Condition Screening
2.2.3 Non-invasive DNA Prenatal Testing Market Size by Type
2.2.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
2.3 Non-invasive DNA Prenatal Testing Segment by Sequencing Method
2.3.1 Whole Genome Sequencing
2.3.2 Targeted Sequencing
2.3.3 Others
2.3.4 Non-invasive DNA Prenatal Testing Market Size by Sequencing Method
2.3.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2026)
2.4 Non-invasive DNA Prenatal Testing Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Non-invasive DNA Prenatal Testing Market Size by Service Model
2.4.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2026)
2.5 Non-invasive DNA Prenatal Testing Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Non-invasive DNA Prenatal Testing Market Size by Application
2.5.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE DNA PRENATAL TESTING MARKET SIZE BY PLAYER
3.1 Non-invasive DNA Prenatal Testing Market Size Market Share by Player
3.1.1 Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
3.2 Global Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DNA PRENATAL TESTING BY REGION
4.1 Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
4.2 Global Non-invasive DNA Prenatal Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.4 APAC Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.5 Europe Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
5.2 Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3 Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
6.2 APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
6.3 APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
7.2 Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive DNA Prenatal Testing by Region (2021-2026)
8.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DNA PRENATAL TESTING MARKET FORECAST
10.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.2 Americas Non-invasive DNA Prenatal Testing Forecast
10.1.3 APAC Non-invasive DNA Prenatal Testing Forecast
10.1.4 Europe Non-invasive DNA Prenatal Testing Forecast
10.1.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast
10.2 Americas Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.2.1 United States Market Non-invasive DNA Prenatal Testing Forecast
10.2.2 Canada Market Non-invasive DNA Prenatal Testing Forecast
10.2.3 Mexico Market Non-invasive DNA Prenatal Testing Forecast
10.2.4 Brazil Market Non-invasive DNA Prenatal Testing Forecast
10.3 APAC Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.3.1 China Non-invasive DNA Prenatal Testing Market Forecast
10.3.2 Japan Market Non-invasive DNA Prenatal Testing Forecast
10.3.3 Korea Market Non-invasive DNA Prenatal Testing Forecast
10.3.4 Southeast Asia Market Non-invasive DNA Prenatal Testing Forecast
10.3.5 India Market Non-invasive DNA Prenatal Testing Forecast
10.3.6 Australia Market Non-invasive DNA Prenatal Testing Forecast
10.4 Europe Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Non-invasive DNA Prenatal Testing Forecast
10.4.2 France Market Non-invasive DNA Prenatal Testing Forecast
10.4.3 UK Market Non-invasive DNA Prenatal Testing Forecast
10.4.4 Italy Market Non-invasive DNA Prenatal Testing Forecast
10.4.5 Russia Market Non-invasive DNA Prenatal Testing Forecast
10.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-invasive DNA Prenatal Testing Forecast
10.5.2 South Africa Market Non-invasive DNA Prenatal Testing Forecast
10.5.3 Israel Market Non-invasive DNA Prenatal Testing Forecast
10.5.4 Turkey Market Non-invasive DNA Prenatal Testing Forecast
10.6 Global Non-invasive DNA Prenatal Testing Forecast by Type (2027-2032)
10.7 Global Non-invasive DNA Prenatal Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-invasive DNA Prenatal Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Natera
11.1.1 Natera Company Information
11.1.2 Natera Non-invasive DNA Prenatal Testing Product Offered
11.1.3 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Natera Main Business Overview
11.1.5 Natera Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Non-invasive DNA Prenatal Testing Product Offered
11.2.3 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Non-invasive DNA Prenatal Testing Product Offered
11.3.3 Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Non-invasive DNA Prenatal Testing Product Offered
11.4.3 MedGenome Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product Offered
11.5.3 Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 SYNLAB
11.6.1 SYNLAB Company Information
11.6.2 SYNLAB Non-invasive DNA Prenatal Testing Product Offered
11.6.3 SYNLAB Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SYNLAB Main Business Overview
11.6.5 SYNLAB Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Non-invasive DNA Prenatal Testing Product Offered
11.7.3 Myriad Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 GGA
11.8.1 GGA Company Information
11.8.2 GGA Non-invasive DNA Prenatal Testing Product Offered
11.8.3 GGA Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GGA Main Business Overview
11.8.5 GGA Latest Developments
11.9 Fulgent Genetics
11.9.1 Fulgent Genetics Company Information
11.9.2 Fulgent Genetics Non-invasive DNA Prenatal Testing Product Offered
11.9.3 Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fulgent Genetics Main Business Overview
11.9.5 Fulgent Genetics Latest Developments
11.10 BillionToOne
11.10.1 BillionToOne Company Information
11.10.2 BillionToOne Non-invasive DNA Prenatal Testing Product Offered
11.10.3 BillionToOne Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BillionToOne Main Business Overview
11.10.5 BillionToOne Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Non-invasive DNA Prenatal Testing Product Offered
11.11.3 BGI Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Berry Genomics
11.12.1 Berry Genomics Company Information
11.12.2 Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
11.12.3 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Genomics Main Business Overview
11.12.5 Berry Genomics Latest Developments
11.13 Annaroad
11.13.1 Annaroad Company Information
11.13.2 Annaroad Non-invasive DNA Prenatal Testing Product Offered
11.13.3 Annaroad Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Annaroad Main Business Overview
11.13.5 Annaroad Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Non-invasive DNA Prenatal Testing Product Offered
11.14.3 Genesky Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product Offered
11.15.3 Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-invasive DNA Prenatal Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Condition Screening
Table 4. Major Players of Expanded Condition Screening
Table 5. Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Whole Genome Sequencing
Table 9. Major Players of Targeted Sequencing
Table 10. Major Players of Others
Table 11. Non-invasive DNA Prenatal Testing Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2021-2026) & ($ millions)
Table 13. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2026)
Table 14. Major Players of Public Health Program
Table 15. Major Players of Consumer
Table 16. Major Players of Others
Table 17. Non-invasive DNA Prenatal Testing Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Non-invasive DNA Prenatal Testing Market Size by Service Model (2021-2026) & ($ millions)
Table 19. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2026)
Table 20. Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 23. Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
Table 25. Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
Table 26. Non-invasive DNA Prenatal Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 31. Global Non-invasive DNA Prenatal Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 35. Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 37. Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 39. APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 41. APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 45. Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Non-invasive DNA Prenatal Testing
Table 51. Key Market Challenges & Risks of Non-invasive DNA Prenatal Testing
Table 52. Key Industry Trends of Non-invasive DNA Prenatal Testing
Table 53. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Natera Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 58. Natera Non-invasive DNA Prenatal Testing Product Offered
Table 59. Natera Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Natera Main Business
Table 61. Natera Latest Developments
Table 62. Labcorp Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 63. Labcorp Non-invasive DNA Prenatal Testing Product Offered
Table 64. Labcorp Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Labcorp Main Business
Table 66. Labcorp Latest Developments
Table 67. Quest Diagnostics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 68. Quest Diagnostics Non-invasive DNA Prenatal Testing Product Offered
Table 69. Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Quest Diagnostics Main Business
Table 71. Quest Diagnostics Latest Developments
Table 72. MedGenome Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 73. MedGenome Non-invasive DNA Prenatal Testing Product Offered
Table 74. MedGenome Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedGenome Main Business
Table 76. MedGenome Latest Developments
Table 77. Mayo Clinic Laboratories Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 78. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product Offered
Table 79. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mayo Clinic Laboratories Main Business
Table 81. Mayo Clinic Laboratories Latest Developments
Table 82. SYNLAB Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 83. SYNLAB Non-invasive DNA Prenatal Testing Product Offered
Table 84. SYNLAB Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. SYNLAB Main Business
Table 86. SYNLAB Latest Developments
Table 87. Myriad Genetics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 88. Myriad Genetics Non-invasive DNA Prenatal Testing Product Offered
Table 89. Myriad Genetics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Latest Developments
Table 92. GGA Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 93. GGA Non-invasive DNA Prenatal Testing Product Offered
Table 94. GGA Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. GGA Main Business
Table 96. GGA Latest Developments
Table 97. Fulgent Genetics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 98. Fulgent Genetics Non-invasive DNA Prenatal Testing Product Offered
Table 99. Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Fulgent Genetics Main Business
Table 101. Fulgent Genetics Latest Developments
Table 102. BillionToOne Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 103. BillionToOne Non-invasive DNA Prenatal Testing Product Offered
Table 104. BillionToOne Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BillionToOne Main Business
Table 106. BillionToOne Latest Developments
Table 107. BGI Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 108. BGI Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 109. BGI Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Main Business
Table 111. BGI Genomics Latest Developments
Table 112. Berry Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 113. Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 114. Berry Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Main Business
Table 116. Berry Genomics Latest Developments
Table 117. Annaroad Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 118. Annaroad Non-invasive DNA Prenatal Testing Product Offered
Table 119. Annaroad Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Main Business
Table 121. Annaroad Latest Developments
Table 122. Genesky Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 123. Genesky Non-invasive DNA Prenatal Testing Product Offered
Table 124. Genesky Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Genesky Main Business
Table 126. Genesky Latest Developments
Table 127. Weihansi Biomedical Technology Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 128. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product Offered
Table 129. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Weihansi Biomedical Technology Main Business
Table 131. Weihansi Biomedical Technology Latest Developments
Table 1. Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-invasive DNA Prenatal Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Condition Screening
Table 4. Major Players of Expanded Condition Screening
Table 5. Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Whole Genome Sequencing
Table 9. Major Players of Targeted Sequencing
Table 10. Major Players of Others
Table 11. Non-invasive DNA Prenatal Testing Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Non-invasive DNA Prenatal Testing Market Size by Sequencing Method (2021-2026) & ($ millions)
Table 13. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method (2021-2026)
Table 14. Major Players of Public Health Program
Table 15. Major Players of Consumer
Table 16. Major Players of Others
Table 17. Non-invasive DNA Prenatal Testing Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Non-invasive DNA Prenatal Testing Market Size by Service Model (2021-2026) & ($ millions)
Table 19. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model (2021-2026)
Table 20. Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 23. Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
Table 25. Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
Table 26. Non-invasive DNA Prenatal Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 31. Global Non-invasive DNA Prenatal Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 35. Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 37. Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 39. APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 41. APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 45. Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Non-invasive DNA Prenatal Testing
Table 51. Key Market Challenges & Risks of Non-invasive DNA Prenatal Testing
Table 52. Key Industry Trends of Non-invasive DNA Prenatal Testing
Table 53. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Natera Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 58. Natera Non-invasive DNA Prenatal Testing Product Offered
Table 59. Natera Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Natera Main Business
Table 61. Natera Latest Developments
Table 62. Labcorp Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 63. Labcorp Non-invasive DNA Prenatal Testing Product Offered
Table 64. Labcorp Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Labcorp Main Business
Table 66. Labcorp Latest Developments
Table 67. Quest Diagnostics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 68. Quest Diagnostics Non-invasive DNA Prenatal Testing Product Offered
Table 69. Quest Diagnostics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Quest Diagnostics Main Business
Table 71. Quest Diagnostics Latest Developments
Table 72. MedGenome Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 73. MedGenome Non-invasive DNA Prenatal Testing Product Offered
Table 74. MedGenome Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedGenome Main Business
Table 76. MedGenome Latest Developments
Table 77. Mayo Clinic Laboratories Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 78. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Product Offered
Table 79. Mayo Clinic Laboratories Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mayo Clinic Laboratories Main Business
Table 81. Mayo Clinic Laboratories Latest Developments
Table 82. SYNLAB Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 83. SYNLAB Non-invasive DNA Prenatal Testing Product Offered
Table 84. SYNLAB Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. SYNLAB Main Business
Table 86. SYNLAB Latest Developments
Table 87. Myriad Genetics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 88. Myriad Genetics Non-invasive DNA Prenatal Testing Product Offered
Table 89. Myriad Genetics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Latest Developments
Table 92. GGA Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 93. GGA Non-invasive DNA Prenatal Testing Product Offered
Table 94. GGA Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. GGA Main Business
Table 96. GGA Latest Developments
Table 97. Fulgent Genetics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 98. Fulgent Genetics Non-invasive DNA Prenatal Testing Product Offered
Table 99. Fulgent Genetics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Fulgent Genetics Main Business
Table 101. Fulgent Genetics Latest Developments
Table 102. BillionToOne Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 103. BillionToOne Non-invasive DNA Prenatal Testing Product Offered
Table 104. BillionToOne Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BillionToOne Main Business
Table 106. BillionToOne Latest Developments
Table 107. BGI Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 108. BGI Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 109. BGI Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Main Business
Table 111. BGI Genomics Latest Developments
Table 112. Berry Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 113. Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 114. Berry Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Main Business
Table 116. Berry Genomics Latest Developments
Table 117. Annaroad Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 118. Annaroad Non-invasive DNA Prenatal Testing Product Offered
Table 119. Annaroad Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Main Business
Table 121. Annaroad Latest Developments
Table 122. Genesky Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 123. Genesky Non-invasive DNA Prenatal Testing Product Offered
Table 124. Genesky Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Genesky Main Business
Table 126. Genesky Latest Developments
Table 127. Weihansi Biomedical Technology Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 128. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Product Offered
Table 129. Weihansi Biomedical Technology Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Weihansi Biomedical Technology Main Business
Table 131. Weihansi Biomedical Technology Latest Developments
LIST OF FIGURES
Figure 1. Non-invasive DNA Prenatal Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-invasive DNA Prenatal Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2025)
Figure 8. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 10. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method in 2025
Figure 11. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model in 2025
Figure 12. Non-invasive DNA Prenatal Testing in Public Hospitals
Figure 13. Global Non-invasive DNA Prenatal Testing Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Non-invasive DNA Prenatal Testing in Private Hospitals
Figure 15. Global Non-invasive DNA Prenatal Testing Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 17. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player in 2025
Figure 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-invasive DNA Prenatal Testing Value Market Share by Country in 2025
Figure 24. United States Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region in 2025
Figure 29. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country in 2025
Figure 38. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 61. China Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 65. India Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 68. France Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 1. Non-invasive DNA Prenatal Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-invasive DNA Prenatal Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2025)
Figure 8. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 10. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Sequencing Method in 2025
Figure 11. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Service Model in 2025
Figure 12. Non-invasive DNA Prenatal Testing in Public Hospitals
Figure 13. Global Non-invasive DNA Prenatal Testing Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Non-invasive DNA Prenatal Testing in Private Hospitals
Figure 15. Global Non-invasive DNA Prenatal Testing Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 17. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player in 2025
Figure 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-invasive DNA Prenatal Testing Value Market Share by Country in 2025
Figure 24. United States Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region in 2025
Figure 29. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country in 2025
Figure 38. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 61. China Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 65. India Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 68. France Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
